B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Capivasertib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Capivasertib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

afuresertib
11 shared targets
uprosertib
13 shared targets
y
11 shared targets
pf
22 shared targets
ripasudil
8 shared targets
hydroxyfasudil
14 shared targets · score 27.5
sar
6 shared targets
fasudil
8 shared targets
gsk
17 shared targets
baricitinib
9 shared targets
Loading evidence profile...

This evidence profile for Capivasertib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.